Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: The Effects of Enoximone in Acute Exacerbation COPD [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating enoximone in acute exacerbation of COPD has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoximone (enoximone)

Snippet

Sponsor: Rijnstate Hospital | Conditions: COPD Exacerbation, Enoximone | Phase 4 | Status: TERMINATED